Efficacy of hydroxychloroquine in the prevention of thromboembolic events: A systematic review and meta-analysis

1. Kitchen, LW, Vaughn, DW, Skillman, DR. Reviews of anti‐infective agents: Role of US military research programs in the development of US food and drug administration–approved antimalarial drugs. Clin Infect Dis 2006; 43: 67–71.
Google Scholar | Crossref | Medline | ISI2. Hoekenga, MT . Treatment of malaria with oral or intravenous plaquenil. Am J Trop Med Hyg 1953; 2: 805–807.
Google Scholar | Crossref | Medline3. Goldman, L . Chloroquine diphosphate in treatment of discoid lupus erythematosus. J Am Med Assoc 1953; 152: 1428.
Google Scholar | Crossref | Medline4. Khraishi, M, Singh, G. The role of anti-malarials in rheumatoid arthritis–the American experience. Lupus 1996; 5: 41–44.
Google Scholar | SAGE Journals5. Kingsbury, SR, Tharmanathan, P, Adamson, J, et al. Hydroxychloroquine effectiveness in reducing symptoms of hand osteoarthritis (HERO): study protocol for a randomized controlled trial. Trials 2013; 14: 64.
Google Scholar | Crossref | Medline6. Morris, SJ, Wasko, MCM, Antohe, JL, et al. Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients. Arthritis Care Res 2011; 63: 530–534.
Google Scholar | Crossref | Medline | ISI7. Smith, GD, Amos, TA, Mahler, R, et al. Effect of chloroquine on insulin and glucose homoeostasis in normal subjects and patients with non-insulin-dependent diabetes mellitus. BMJ 1987; 294: 465–467.
Google Scholar | Crossref | Medline8. Kravvariti, E, Koutsogianni, A, Samoli, E, et al. The effect of hydroxychloroquine on thrombosis prevention and antiphospholipid antibody levels in primary antiphospholipid syndrome: A pilot open label randomized prospective study. Autoimmun Rev 2020; 19: 102491.
Google Scholar | Crossref | Medline9. Knisely, MH, Stratman-Thomas, WK, Eliot, TS. Capillary circulation in the malarial infected monkey—A cinematographic study. J Am Med Assoc 1941; 116: 2430–2431.
Google Scholar10. Madow, BP . Use of antimalarial drugs as “desludging” agents in vascular disease processes preliminary report. J Am Med Assoc 1960; 172: 1630.
Google Scholar | Crossref | Medline11. Carter, AE, Eban, R, Perrett, RD. Prevention of postoperative deep venous thrombosis and pulmonary embolism. Br Med J 1971; 1: 312–314.
Google Scholar | Crossref | Medline12. Ruiz-Irastorza, G, Ramos-Casals, M, Brito-Zeron, P, et al. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis 2010; 69: 20–28.
Google Scholar | Crossref | Medline | ISI13. Edington, FLB, Gadelha, SR, Santiago, MB. Safety of treatment with chloroquine and hydroxychloroquine: A ten-year systematic review and meta-analysis. Eur J Intern Med 2021; 88: 63–72.
Google Scholar | Crossref | Medline14. Shamseer, L, Moher, D, Clarke, M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 2015; 349: g7647.
Google Scholar | Crossref | Medline15. Sterne, JAC, Savović, J, Page, MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019; 2019: l4898.
Google Scholar | Crossref16. Higgins, J, Thomas, J, Chandler, J, et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021) [Internet]. www.training.cochrane.org/handbook (accessed 2 March 2021)
Google Scholar17. Higgins, JPT, Thompson, SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539–1558.
Google Scholar | Crossref | Medline | ISI18. Egger, M, Smith, GD, Schneider, M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629–634.
Google Scholar | Crossref | Medline19. Erkan, D, Unlu, O, Sciascia, S, et al. Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease. Lupus 2018; 27: 399–406.
Google Scholar | SAGE Journals | ISI20. Tektonidou, MG, Andreoli, L, Limper, M, et al. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis 2019; 78: 1296–1304.
Google Scholar | Crossref | Medline

留言 (0)

沒有登入
gif